Object. The purpose of this study was to evaluate and compare the long-term effects of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on blood pressure (BP).
H ypertension remains the most important welldocumented, modifiable risk factor for stroke, and treating hypertension is among the most effective treatment strategies for preventing both ischemic and hemorrhagic stroke. 6 Blood pressure instability in the immediate postprocedural period is a common occurrence after carotid artery stenosis treatment with either CEA or CAS. Hypotension or hypertension can occur, which may result in a prolonged hospital stay or neurological complications. However, to the best of our knowledge, the long-term effects of CEA or CAS on BP changes have not been well evaluated. The aim of this study was to evaluate and compare the long-term effects between CEA and CAS on BP.
Methods
This retrospective study was approved by our institutional review board, and the need for patient informed consent was waived. Between January 2003 and December 2009, 134 patients underwent 145 procedures for the treatment of carotid artery stenosis by either CEA or CAS. Among these patients, those who had at least 1 year of clinical and radiographic follow-up after treatment were included in this study. After exclusion of 32 patients (23 patients were lost to follow-up, 6 died, and 3 underwent balloon angioplasty only), a total of 102 patients constituted the population of this study. These patients were placed in the CEA group (n = 59) or the CAS group (n = 43) according to their treatment. Among them, 2 patients underwent bilateral CAS, 3 patients underwent bilateral CEA, and 1 patient underwent CAS on one side and CEA on the other. For the 6 patients who underwent bilateral procedures, 2 (4.7%) were included in the CAS group and 4 (6.8%) were included in the CEA group.
The SBP and DBP were measured at the following 4 different time points: pretreatment, posttreatment, the 1-month follow-up, and the 1-year follow-up. Noninvasive BP monitoring was used for routine BP measurements. The pretreatment, posttreatment, 1-month follow-up, and 1-year follow-up BPs were calculated by averaging the noninvasive BP values for 24 hours at the pretreatment Effects of carotid artery stenosis treatment on blood pressure Clinical article and the posttreatment time points, and for 1 month (twice a day; immediately after awaking in the morning and before sleep at night) at the 1-month follow-up period, and 1 month prior to the 1-year follow-up time point. Before the procedure, an assigned nurse measured BP every 2 hours for 24 hours using an automatic arm manometer. After the procedure, the nurse measured BP every hour for 8 hours and then every 2 hours for 16 hours. During the follow-up period, most of the patients were instructed on how to measure their BP in their left arm in the sitting position at home with the aid of commercial automatic BP measuring equipment.
The average SBP and DBP values at each time point were evaluated in each group. In addition, the percentage change in the SBP decrement at each time point was calculated using the following equation and was compared between the groups: percentage change in SBP decrement = {(SBP n -SBP 0 )/SBP n } × 100, (n = 1, 2, or 3), where SBP 0 , SBP 1 , SBP 2 , and SBP 3 represent the pretreatment BP, the posttreatment BP, the 1-month follow-up BP, and the 1-year follow-up BP, respectively. The percentage change in the DBP decrement was calculated using the equivalent equation.
A normotensive BP was defined when the SBP/DBP decreased to lower than 120/80 mm Hg after the procedures. The number of patients with a normotensive BP and the change in the number of antihypertensive drugs taken by the patients at each time point were evaluated and compared. The antihypertensive drugs consisted of diuretics, calcium channel blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and/ or beta blockers in a single or combined regimen.
Surgical Management
All CEA procedures were performed under general anesthesia with somatosensory evoked potential and/ or electroencephalography monitoring. If preoperative transfemoral cerebral angiography showed that there was not enough cross-filling during the Matas Test and the Alcock Test, carotid shunts were used during CEA. A local lidocaine infiltration at the carotid sinus was performed only when the patient's heart rate was lower than 40 bpm. A local injection was performed in 8 (13.6%) of 59 patients in this study. When closing the carotid artery after plaque removal, we preferred continuous-suture closure for artery repair rather than carotid patch angioplasty.
Carotid artery stenting was routinely performed after administration of a local anesthetic and with strict BP monitoring. Among the 43 patients enrolled in this study, a distal embolic protection device was used in the 38 most recently treated patients. A self-expanding nitinol stent was used for all patients undergoing CAS.
Statistical Analysis
Statistical analyses were conducted using SPSS (version 13.0, SPSS, Inc.). We evaluated the significance of BP changes between the pretreatment and follow-up periods by using a paired t-test. The baseline characteristics, procedure-related complications, restenosis rates, changes in the number of drugs, and the percentage change in BP decrement between the groups were evaluated using the Student t-test. Probability values < 0.05 were considered statistically significant. Mean values are presented as the mean ± SD.
Results
The baseline characteristics of each group are shown in Table 1 . The mean age was younger in the CEA group (63.6 ± 7.0 years) than in the CAS group (67.0 ± 8.1 years, p = 0.032). Symptomatic lesions were found in 45 patients (76.3%) in the CEA group and in 32 patients (74.4%) in the CAS group (p = 0.832). The mean stenosis rates were 81.3% ± 14.4% in the CEA group and 77.5% ± 12.9% in the CAS group (p = 0.175). There were no significant differences between the groups for the other baseline characteristics, including the presence of hypertension, diabetes, hypercholesterolemia, alcohol intake, body mass index, atrial fibrillation, or the proportion of the patients who underwent bilateral procedures. The mean number of antihypertensive drugs at the pretreatment time point was 1.29 ± 0.81 in the CEA group and 1.47 ± 0.85 in the CAS group (p = 0.290). Procedure-related complications (5.1% in the CEA group and 2.3% in the CAS group, p = 0.431) and the restenosis rate 1 year after the procedure (1.7% in the CEA group and 7.0% in the CAS group, p = 0.483) were not significantly different between the groups.
The mean SBPs and DBPs for each time point are shown in Fig. 1 . Compared with the pretreatment BPs, the follow-up BPs were significantly decreased in each group after treatment. In the CEA group, the mean SBP/ DBP values were 122.5/73.0, 125.4/75.5, and 129.5/77.7 mm Hg at the posttreatment time point, the 1-month follow-up, and the 1-year follow-up, respectively. Compared with 136.9/83.5 mm Hg at the pretreatment time point, the BPs in the CEA group were significantly decreased (p < 0.01). In the CAS group, the mean SBP/DBP values were 122.7/76.2, 127.2/78.5, and 128.5/77.3 mm Hg at the posttreatment time point, the 1-month follow-up, and the 1-year follow-up, respectively. Compared with 140.7/87.2 mm Hg at the pretreatment time point, the mean BPs in the CAS group were also significantly decreased (p < 0.01). In both groups, the SBP and DBP were significantly decreased after the procedure, and the values tended to increase slightly afterward until the 1-year follow-up. The follow-up BPs were significantly lower than the pretreatment BPs. Table 2 shows the percentage changes in the BP decrement at each time point compared with the pretreatment BP. The patients in the CEA group had a 12.6%, 9.3%, and 5.9% SBP decrement and a 15.9%, 11.8%, and 8.1% DBP decrement at the posttreatment time point, the 1-month follow-up, and the 1-year follow-up, respectively. The patients in the CAS group had a 15.1%, 11.1%, and 9.6% SBP decrement and a 15.3%, 11.6%, and 12.8% DBP decrement at the posttreatment time point, the 1-month follow-up, and the 1-year follow-up, respectively. The percentage change in the SBP decrement at the 1-year follow-up in the CAS group was greater (p = 0.035) than that in the CEA group (Fig. 2) . In addition, the percentage change in the DBP decrement at the 1-year follow-up in the CAS group was greater (p = 0.049) than that in the CEA group.
Compared with pretreatment BP, the CAS group comprised a greater percentage of patients with a normotensive BP at the follow-up time points than the CEA group (Table 3) . At the 1-month follow-up, 29 patients (49.2%) in the CEA group and 22 patients (51.2%) in the CAS group exhibited a decrease in SBP/DBP to lower than 120/80 mm Hg, which was not significantly different between the groups (p = 0.695). Yet at the 1-year followup, there were significantly more patients with a normotensive BP in the CAS group (46.5%) than in the CEA group (22.0%, p = 0.012). In contrast, 5 patients (8.5%) in the CEA group and 2 patients (4.7%) in the CAS group had hypertension (SBP/DBP ≥ 140/90 mm Hg) during the immediate postprocedural period. At the 1-year followup, postprocedural hypertension occurred in 2.9% of the patients overall (2 in the CEA group and 1 in the CAS Compared with the pretreatment BP, the follow-up BPs were significantly decreased after CEA or CAS. In both groups, the BPs were significantly decreased after the procedure, and they tended to increase slightly afterward until the 1-year follow-up. *p < 0.01. Tx = treatment. The horizontal lines in the boxes indicate the median. The error bars represent the ranges, and the boxes represent the lower quartile (25%) and upper quartile (75%) values. group). The number of antihypertensive drugs taken by the patients was not significantly changed at the follow-up time points. Compared with the mean number of pretreatment drugs taken, there were no significant changes at the follow-up time points (1-month and 1-year follow-up) between the groups. However, 2 patients (4.7%) in the CAS group and 18 patients (30.5%) in the CEA group (p = 0.043) at the 1-year follow-up were taking more antihypertensive drugs (Table 4) .
Discussion
Carotid artery stenosis can currently be treated using CEA or CAS. During these procedures, periprocedural hemodynamic instabilities, such as hypotension, bradycardia, or hypertension, are often encountered. 1, [11] [12] [13] [14] 17, 20 Hypertension has been noted with a frequency of 9%-38% after CEA 18, 20 and 39% after CAS. 16 A wide variation in the frequency of hypotension has been observed after CEA (12%-50%) 2,20 and after CAS (18.8%-56.1%). 4, 8 Since there are few reports for the long-term follow-up of BP changes after treatment of carotid artery stenosis, we evaluated the long-term effects of carotid artery stenosis treatment on BP, and we compared the effects between CEA and CAS. In this study, a low frequency of episodes of increased BP was noted at the 1-year follow-up (2.9% of the patients with SBP/DBP > 140/90 mm Hg), but a much higher frequency of episodes of normotensive BP (SBP/ DBP < 120/80 mm Hg) was observed at the 1-year followup (22.0% after CEA and 46.5% after CAS, Table 3 ). The CAS group showed a greater frequency of normotensive BP than the CEA group. Although the pretreatment BP was slightly lower in the CEA group, the 1-year followup BP was lower in the CAS group (Fig. 1) . In addition, the percentage changes of SBP and DBP were greater in the CAS group at the 1-year follow-up than in the CEA group, indicating that CAS has a greater tendency for BPlowering effects than CEA.
Damage to the carotid baroreceptor is an important cause of periprocedural hemodynamic instability. The adventitial baroreceptors in the carotid sinus, which is the dilated segment of the internal carotid artery at its origin from the common carotid artery, are stretch receptors. The arterial wall of the carotid sinus is thinner than that of other arteries of the same caliber. Increased firing of these baroreceptors inhibits sympathetic neurons in the tractus solitarius nucleus, which reduces the sympathetic tone in the peripheral blood vessels, leading to a reduction in systemic BP. Atherosclerosis and hypertension lower the baroreceptors' sensitivity because the carotid sinus becomes stiffer and more resistant to deformation. In this study, it might be suggested that CAS has a greater tendency for a BP-lowering effect, possibly because of greater compliance and an increase in the diameter of the arterial segment after the angioplasty. Furthermore, the radial force of the stent imparts chronic mechanical pressure over the carotid sinus.
1 On the other hand, even though CEA can result in optimal BP control in a patient with treatment-resistant hypertension, 9 CEA may induce the surgical denervation of the carotid sinus nerve or induce dysfunction of the carotid baroreceptors during the procedure, leading to less reduction in BP at the longterm follow-up.
In this study, more patients had carotid artery stenosis on the right side in the CEA group (62.7%) than in the CAS group (25.6%, p = 0.006). The difference in the laterality of the carotid artery stenosis might affect the results of this study since some studies in humans have suggested some laterality of the carotid sinus output. Williamson et al. 19 suggested that afferent input from the left carotid sinus might have a greater influence on efferent muscle sympathetic outflow. Diedrich et al. 5 suggested the presence of a right-sided lateralization of carotid baroreceptor output. These authors concluded that right lateralization of the sympathetic activity to the vessels is indicated by normalized burst strength parameters of bilateral muscle sympathetic nerve activity recordings. According to their study, treating one side of the carotid artery stenosis might have a greater BP-lowering effect than treating the other side. On the other hand, Furlan et al. 7 concluded that there was no asymmetry in the neural sympathetic discharge responses after single-sided carotid baroreceptor stimulation. In this study, BP-lowering effects were observed in both groups despite the fact that there were more left-sided lesions in the CAS group than the CEA group. In addition, there was insufficient evidence to explain why the lateralization of the carotid sinus output had a better long-term (1-year follow-up) BP-lowering effect in the CAS group. Overall, a complete understanding of the lateralization of the carotid sinus output is difficult to arrive at from the current data.
Blood pressure management plays a crucial role in the prevention of stroke. Any decrease in BP is associated with a decrease in the relative risk of stroke. 10 A study of antihypertensive treatment in patients with a history of cerebrovascular events found that a reduction of 9/4 mm Hg was associated with a reduced risk of stroke of 28%, so even small decreases in BP are highly effective.
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In this study, the long-term effect of CAS is associated with greater sustained reduction of BP than that associated with CEA, which means that CAS may have better effects on BP control than CEA after treating carotid artery stenosis. Therefore, CAS may have a better effect on the secondary prevention of stroke than CEA, and it may be worth further studying the effect of this greater BP lowering of CAS than CEA on the secondary prevention of stroke.
Even though there were some changes in the number of antihypertensive drugs taken by the patients in each group during the follow-up periods, there were no significant differences between the groups except for the numbers of the drugs that were being taken at the 1-year follow-up (Table 4 ). More patients in the CEA group (30.5%) were taking antihypertensive drugs at the 1-year follow-up than those in the CAS group (4.7%, p = 0.043). However, CAS treatment had a longer-term effect on BP control than CEA treatment, which indicated that the number of antihypertensive drugs may not affect the BPlowering effect of carotid artery stenosis treatment.
The limitations of this study include its retrospective design, which excluded randomization and access to certain data. It was very difficult, for example, to analyze the dosage changes of the antihypertensive drugs, and therefore such an analysis was not done in this study. Some previous studies excluded patients who changed their antihypertensive drugs.
11 However, we analyzed the changes in the number of drugs, and we attempted to evaluate the correlation between the number of antihypertensive drugs and the BP-lowering effects. Finally, we examined the average of the noninvasive BP values rather than ambulatory BP values. 3, 21 Noninvasive BP measurements are less reliable than ambulatory BP measurements as a representative measure. We routinely educate patients to check their BP twice a day to control their BP during the follow-up period. To help eliminate factors that reduce the reliability of single blood pressure values, the BPs were calculated by averaging the noninvasive BP values for 24 hours pre-and posttreatment, and for 1 month (twice a day) at the 1-month follow-up and the 1-year follow-up. 
